Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 192381, 9 pages
http://dx.doi.org/10.1155/2011/192381
Research Article

Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission

1Consolidated Research Institute for Advanced Science and Medical Care, Waseda University (ASMeW), 513 Wasedatsurumaki-cho, Shinjuku-ku, Tokyo 162-0041, Japan
2Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8640, Japan
3Department of Urology, Gengendo Kisarazu Clinic, 4737 Takayanagi, Kisarazu, Chiba 292-0014, Japan
4Department of Urology, Shikoku Cancer Center, 160 Ko, Minamiumemoto-machi, Matsuyama, Ehime 791-0280, Japan

Received 31 October 2009; Revised 27 September 2010; Accepted 17 February 2011

Copyright © 2011 Satoshi Ohno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Satoshi Ohno, Yoshiteru Sumiyoshi, Katsuyoshi Hashine, Akitomi Shirato, Satoru Kyo, and Masaki Inoue, “Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 192381, 9 pages, 2011. https://doi.org/10.1155/2011/192381.